Molecular aspects of hepatocellular carcinoma;Molekulare Aspekte des hepatozellularen Karzinoms

Zentralblatt fur Chirurgie

Volumn 125, Issue 7, 2000, Pages 592-596

  Moradpour, D ^b   Blum, H E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE

Author keywords

Aflatoxin B1; DNA mismatch repair; Hepatitis B virus; Hepatitis C virus; Oncogenes; Tumor suppressor genes

Indexed keywords

AFLATOXIN; AFLATOXIN B1; GROWTH FACTOR; PROTEIN P53; TELOMERASE; DNA; GROWTH PROMOTOR;

BASE MISPAIRING; CELL TRANSFORMATION; DNA REPAIR; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; GENE ACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER REGENERATION; ONCOGENE; REVIEW; RISK FACTOR; TUMOR SUPPRESSOR GENE; ADULT; AGE; ALCOHOLISM; ANIMAL; ARTICLE; CHILD; COHORT ANALYSIS; GENETICS; HEPATITIS B; LIVER TUMOR; METABOLISM; MIDDLE AGED; MOUSE; MUTATION; SCIURIDAE; TRANSGENIC MOUSE;

ADULT; AFLATOXIN B1; AGE FACTORS; ALCOHOLISM; ANIMALS; CARCINOMA, HEPATOCELLULAR; CHILD; COHORT STUDIES; DNA; DNA REPAIR; ENZYME ACTIVATION; GENES, P53; GROWTH SUBSTANCES; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MARMOTA; MICE; MICE, TRANSGENIC; MIDDLE AGED; MUTATION; RISK FACTORS; TELOMERASE;

EID: 0033661030     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Aguilar F, Hussain SP, Cerutti P. Aflatoxin B1 induces the transversion of G → T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 1993; 90: 8586-8590
2. Beasley RP, Hwang L-Y, Lin C-C, Chien C-S. Hepatocellular carcinoma and hepatitis B virus - a prospective study of 22 707 men in Taiwan. Lancet 1981; II: 1129-1133
3. Becker SA, Lee T-H, Butel JS, Slagle BL. Hepatitis B virus X protein interferes with cellular DNA repair. J Virol 1998; 72: 266-272
4. Benn J, Schneider RJ. Hepatitis B virus X protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 1994; 91: 10350-10354
5. Blum HE. Does hepatitis C virus cause hepatocellular carcinoma. Hepatology 1994; 19: 251-255
6. Blum HE. Tumoren der Leber und des biliären Systems. In: Gerok W, Blum HE (Hrsg). Hepatologie. 2. Aufl. Urban & Schwarzenberg, München 1995; 635-650
7. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 429-431
8. Buendia MA. Hepatitis B viruses and hepatocellular carcinoma. Adv Cancer Res 1992; 59: 167-226
9. Cariani E, Lasserre C, Kemeny F, Franco D, Bréchot C. Expression of insulin-like growth factor II, α-fetoprotein, and hepatitis B virus transcripts in human primary liver cancer. Hepatology 1991; 16: 644-649
10. Caselmann WH, Koshy R. Transactivators of HBV, signal transduction and tumorigenesis. In: Caselmann WH, Koshy R (Hrsg). Hepatitis B virus. 1. Aufl. Imperial College Press, London 1998
11. Chang M-H, Chen C-J, Lai M-S, Hsu H-M, Wu T-C, Kong M-S, Liang D-C, Shau W-Y, Chen D-S, for the Taiwan Childhood Hepatoma Study Group. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336: 1855-1859
12. Colombo M, Cambieri R, Rumi MG, Ronchi G, del Ninno P, de Franchis R. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepattis. Gastroenterology 1983; 85: 235-239
13. Cross M, Dexter TM. Growth factors in development, transformation and tumorigenesis. Cell 1991; 64: 271-280
14. Dejean A, de Thé H. Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinoma. Mol Biol Med 1990; 7: 213-222
15. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 1987; 47: 707-712
16. Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet 1998; 351: 214-215
17. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology 1997; 26 (Suppl 1): 34S-38S
18. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750
19. Fausto N, Webber EM. Mechanisms of growth regulation in liver regeneration and hepatic carcinogenesis. In: Boyer JL, Ockner RK (Hrsg). Progress in liver diseases. Saunders, Philadelphia 1993; 115-137
20. Gerin JL, Cote PJ, Korba BE, Miller RH, Purcell RH, Tennant BC. Hepatitis B virus and liver cancer: the woodchuck as an experimental model of hepadnavirus-induced liver cancer. In: Hollinger FB, Lemon SM, Margolis H (Hrsg). Viral hepatitis and liver disease. Williams & Wilkins, Baltimore 1991; 556-559
21. Haber DA. Telomeres, cancer, and immortality. N Engl J Med 1995; 332: 955-956
22. Höhne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich WH. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 1990; 9: 1137-1145
23. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427-428
24. Ito T, Sasaki Y, Wands JR. Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases. Mol Cell Biol 1996; 16: 943-951
25. Kew MC. Tumors of the liver. In: Zakim D, Boyer TD (Hrsg). Hepatology - a textbook of liver disease. 3. Aufl, Saunders, Philadelphia 1996; 1513-1548
26. Kim C-M, Koike R, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317-320
27. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific as sociation of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015
28. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-170
29. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-675
30. Matsubara K, Tokino T. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol Biol Med 1990; 7: 243-260
31. Mohamed AE, Kew MC, Groeneveld HT. Alcohol consumption as a risk factor for hepatocellular carcinoma in urban southern African blacks. Int J Cancer 1992; 51: 537-541
32. Moradpour D, Wands JR. The molecular pathogenesis of hepatocellular carcinoma. J Viral Hepatitis 1994; 1: 17-31
33. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065-1067
34. Nakamoto Y, Guidotti LC, Kuhlen CV, Fowler P, Chisari FV. Immune pathogenesis of hepatocellular carcinoma. J Exp Med 1998; 188: 341-350
35. Nishiyama M, Wands JR. Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma. Biochem Biophys Res Commun 1992; 183: 280-285
36. Ozturk M. Chromosomal rearrangements and tumor suppressor genes in primary liver cancer. In: Bréchot C (Hrsg). Primary liver cancer: etiological and progression factors. CRC Press, Boca Raton 1994; 269-281
37. Pasquinelli C, Bhavani K, Chisari FV. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Res 1992; 52: 2823-2829
38. Pilot HC. Proto-oncogene activation in multistage murine hepatocarcinogenesis. Prog Clin Biol Res 1990; 331: 311-324
39. Puisieux A, Lim S, Groopman J, Ozturk M. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res 1991; 51: 6185-6189
40. Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 1996; 70: 4438-4443
41. Ray RB, Steele R, Meyer K, Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 1997; 272: 10983-10986
42. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT, Henderson BE. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339: 943-946
43. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995; 69: 3893-3896
44. Santoni-Rugiu E, Preisegger KH, Kiss A, Audolfsson T, Shiota G, Schmidt EV, Thorgeirsson SS. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc Natl Acad Sci USA 1996; 93: 9577-9582
45. Shiota G, Rhoads DB, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA 1992; 89: 373-377
46. Shiota G, Wang TC, Nakamura T, Schmidt EV. Hepatic growth factor in transgenic mice: effect on hepatocyte growth, liver regeneration and gene expression. Hepatology 1994; 19: 962-972
47. Shirai Y, Kawata S, Ito N, Tamura S, Takaishi K, Kiso S, Tsushima H, Matsuzawa Y. Elevated levels of plasma transforming growth factor-β in patients with hepatocellular carcinoma. Jpn J Cancer Res 1992; 83: 676-679
48. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G, Ide T. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55: 2734-2736
49. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-1994. Lancet 1997; 350: 1142-1143
50. Tennant BC. Hepatocarcinogenesis in experimental woodchuck hepatitis virus infection. In: Sirica AE (Hrsg). The role of cell types in hepatocarcinogenesis. CRC Press, Boca Raton 1992; 323-349
51. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G. Functional inactivation but not structural mutation of p53 causes liver cancer. Nature Genet 1995; 9: 41-47
52. Wands JR, Blum HE. Primary hepatocellular carcinoma. N Engl J Med 1991; 325: 729-731
53. Wang J, Chenivesse X, Henglein B, Bréchot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 1990; 434: 555-557
54. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu J-R, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994; 91: 2230-2234